An investigation on behalf of investors in NASDAQ:OREX shares was announced concerning possible breaches of fiduciary duties by certain Orexigen Therapeutics directors.
Investors who purchased shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Orexigen Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Orexigen Therapeutics, Inc. reported that its annual Total Revenue rose from $24.46 million in 2105 to $33.71 million in 2016 and that its Net Loss declined from $68.69 million in 2015 to $24.52 million in 2016.
Shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) closed on April 27, 2017 at $3.61 per share.
Those who purchased NASDAQ:OREX shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
[email protected]
The post NASDAQ:OREX Investor News: Investigation of Orexigen Therapeutics, Inc. announced appeared first on GroundReport.
This post first appeared on 6 Surprising Benefits Of Custom Graphic Design To Build Your Brand, please read the originial post: here
